Virtuoso Therapeutics to present at AACR annual meeting

By The Science Advisory Board staff writers

March 28, 2022 -- Virtuoso Therapeutics will present two posters at the American Association for Cancer Research (AACR) 2022 annual meeting. The posters will highlight the company's preclinical data from its leading bispecific antibody programs, the company said.

The poster, "Multiple modes of action of the CD38 x ICAM-1 bispecific antibody" (5385), will be presented on Friday, April 8, 12-1 p.m. CT. The other poster, "CD47 x ICAM-1 bispecific antibody represents a novel approach for treating ICAM-1 overexpressing tumors" (3430) will be presented on Tuesday, April 12, 1:30-5 p.m. CT.


Copyright © 2022 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.